Skip to main content
. 2018 Jun 23;33:218–229. doi: 10.1016/j.ebiom.2018.06.019

Fig. 3.

Fig. 3

Serum metabolomic profile of H7N9-infected patients as determined by UPLC-MS. (A) Supervised (OPLS-DA) score scatter plot of H7N9-infected patients receiving steroid treatment (H7N9 + steroid) and healthy controls (healthy) from the UPLC-MS data. (B) Heat map of significantly altered metabolites detected by UPLC-MS. Hierarchical clustering of the 23 metabolites is shown between the healthy group (n = 9) and H7N9 + steroid group (n = 4) in the discovery analysis.